Frequencies of genomic alterations in tumor samples—Results are displayed for genomic alterations present in at least 7% of tumor specimens and tested in at least 20% of the tumor specimens, as well as NRAS and MED12. Frequencies do not reflect OncoKB annotation. This evidence concerns the gene MED12 and neoplasm.